SEARCH   ECU WebsitePeople GO

Pathology & Laboratory Medicine
Faculty Listing

Lorita Rebellato-de Vente, Ph.D.

Associate Professor

Scientific Director HLA-Tissue
  Transplantation Laboratory


Phone:  252-744-5007

Fax:  252-744-1889



Staff & Students

Residency Program

Graduate Studies

Pathology Assistant Training

Grand Rounds

Pathology as a Career

Students Interested in Pathology

Department Reports

Department Job Openings
ECU Home







Faculty Rank

Associate Professor


Undergraduate Education

Federal University of Paraná, Curitiba, Paraná - Brazil, B.S. (Pharmacy/Biochemistry)


Graduate Education

East Carolina University, Greenville, NC, M.S. (Biology)

East Carolina University, Greenville, NC  Ph.D. (Microbiology/Immunology)



American Board of Histocompatibility and Immunogenetics


Clinical Interests

Histocompatibility Testing and Transplantation


Research Interests

Transplantation Immunobiology, Post-Transplant Follow Up, Donor-Specific Hyporesponsiveness, Cytokine Gene Polymorphisms, Xenotransplantation


Selected Publications

1.  Everly MJ, Rebellato LM, Ozawa M, Briley KP, Catrou PG, Haisch CE,  and  Terasaki PI. Lowering HLA Antibody to Improve Renal Allograft Survival.   Transplantation 20 (20): 1-6, 2010.


2.  Nikaein A, Cherikh W, Nelson K, Baker T, Leffell S, Bow L, Crowe D, Connick K, Head MA, Kamoun M, Kimball P, Klohe E, Noreen H, Rebellato L, Sell T, Sullivan K and Land G. Organ Procurement and Transplantation Network /United Network for Organ Sharing Histocompatibility Committee Collaborative Study to Evaluate Prediction of Crossmatch Results in Highly Sensitized Patients. Transplantation 87: 557-562, 2009.


3.  Stubenitsky BM, Brasile L, Rebellato LM, Hawinkles H, Haisch C, and Kon M. Delayed skin allograft rejection following matrix membrane pretreatment. Journal of Plastic, Reconstructive & Aesthetic Surgery 62:520525, 2009.


4.  Mao Q, Terasaki PI, Cai J, Briley K, Catrou P, Haisch C, and Rebellato L. Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a 5-year longitudinal study.  American Journal of Transplantation 7(4): 864-871, 2007.


5.  Mao Q, Terasaki PI, Cai J, El-Awar N, and Rebellato L. Analysis of HLA Class I Specific Antibodies in Patients with Failed Grafts. Transplantation 83 (1): 54-61, 2007.


6.  Cai J, Terasaki PI, Mao Q, Pham T, El-Awar N, Lee JH, and Rebellato L. Development of Nondonor-Specific HLA-DR Antibodies in Allograft Recipients is Associated with Shared Epitopes with Mismatched Donor DR Antigens.  American Journal of Transplantation 6 (12): 2947-2954, 2006.


7.  Rebellato LM, Verbanac KM, and Haisch CE. The current status of xenotransplantation. Current Surgery 62(5):481-488, September/October, 2005.  


8.  Rebellato LM, Arnold AN, Bozik KM, and Haisch CE. HLA matching and the United Network for organ sharing (UNOS) allocation system: impact of HLA matching on african American recipients of cadaveric kidney transplants. Transplantation 74(11): 1634-1636, December, 2002.  



Contributions to Texbooks

1.  Rebellato LM, Everly MJ, Haisch CE, Ozawa M, Briley KP, Parker K, Catrou PG,  Bolin P, Kendrick WT, Kendrick SA, and Harland RC.  A Report of the Epidemiology of De Novo Donor-Specific Anti-HLA Antibodies (DSA) in “Low-Risk” Renal Transplant Recipients. Clinical Transplants 2011; 2012.


2.  Rebellato LM, Ozawa M, Verbanac KM, Catrou P, Haisch CE, and Terasaki PI. Clinical and Anti-HLA Antibody Profile of Nine Renal Transplant Recipients with Failed Grafts: Donor-specific and Non-Donor-Specific Antibody Development. Clinical Transplants 2006; 2007.


3.  Ozawa M, Rebellato LM, Terasaki PI, Tong A, Briley KP, Catrou P, and Haisch C. Longitudinal testing of 266 renal allograft patients for HLA antibodies: Greenville experience. Clinical Transplants 2006; 2007.


4.  Verbanac KM, Rebellato LM and Haisch CE. “The Immune System and the Immunocompromised Patient”, in Physiological Basis of Modern Surgical Care (Thomas Miller, Ed., 4th edition), Quality Medical Publishing. St Louis, MO, 2006.




Selected Presentations

1.  Hewan-Lowe K, Rebellato L, Finley J, Nzerue C. Location of Post Transplant Neoplasia Influences Diagnosis and Graft Outcome. Poster presented at the American Society of Nephrology; Nov 12-17, 2003; San Diego, CA.


2.  Rebellato LM, Briley KP, Hewan-Lowe K. Serum anti-HLA antibody and C4d staining of allograft biopsies are adequate tools for the diagnosis of humoral rejection. Poster presented at the 29th Annual Meeting of American Society for Histocompatibility and Immunogenetics; Oct 30, 2003; Miami, FL.


3.  Arnold AN, Rebellato LM. Cadaveric renal transplants without delayed graft function have outcomes equivalent to living donor renal transplants: a six-year experience from two transplant centers. Poster presented at the American Transplant Congress 2003; Jun 3, 2003; Washington, DC.


4.  Sutton AT, Rebellato-de Vente L, and Hewan-Lowe KO.  Small viral particles lead to major disease in renal transplant. Presented at the Ultrastructure Meeting; Aug 2002; Aspen, Colorado.



ecu logo Contact Us
Pathology & Laboratory Medicine
Brody School of Medicine at ECU
Brody Medical Sciences Building 7S10
Greenville, NC  27858-4353 USA
© 2009 | terms of use | Last Updated: 05/31/2012